Produktname:Triphenylmethyl chloride

IUPAC Name:

CAS:76-83-5
Molekulare Formel:C19H15Cl
Reinheit:95%+
Katalognummer:CM000181
Molekulargewicht:278.78

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM000181-500g 1-2 Weeks ƼƋ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:76-83-5
Molekulare Formel:C19H15Cl
Schmelzpunkt:-
SMILES-Code:ClC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3
Dichte:
Katalognummer:CM000181
Molekulargewicht:278.78
Siedepunkt:
Mdl-Nr.:MFCD00000813
Lagerung:

Column Infos

Zegocractin
CalciMedica announces positive topline data from phase 2b CARPO trial of Auxora™ in Acute Pancreatitis (AP). The trial met primary objective with statistically significant dose response. Calcium release–activated calcium (CRAC) channels are involved in activating T cells, and responsible for regulating calcium-dependent inflammatory pathways or tissue cell injury pathways. AP is a potentially life-threatening inflammatory disease of the pancreas featured by aberrant signaling of calcium.
CalciMedica’s Auxora is a potent and selective intravenous formulated CRAC channel inhibitor containing the active ingredient Zegocractin. It is being developed for the treatment of acute inflammatory and immunologic illnesses, including severe AP, AIPT, AKI, and severe acute respiratory diseases including AHRF, and ARDS.